Table I.
Baseline characteristics of the patients.
| Characteristics | Arm Aa (n=25) | Arm Bb (n=21) |
|---|---|---|
| Age, year | ||
| Median | 65 | 61 |
| Range | 43–73 | 46–80 |
| Gender (%) | ||
| Male | 19 (76.0) | 17 (80.9) |
| Female | 6 (24.0) | 4 (19.1) |
| Depth of tumor invasion (%) | ||
| T1 | 0 (0) | 0 (0) |
| T2 | 14 (56.0) | 11 (52.4) |
| T3 | 11 (44.0) | 10 (47.6) |
| T4 | 0 (0) | 0 (0) |
| Lymph node metastasis (%) | ||
| N0 | 4 (16.0) | 3 (14.3) |
| N1 | 11 (44.0) | 11 (52.4) |
| N2 | 10 (40.0) | 7 (33.3) |
| N3 | 0 (0) | 0 (0) |
| Pathological stage (%) | ||
| II | 10 (40.0) | 10 (47.6) |
| IIIA | 9 (36.0) | 8 (38.1) |
| IIIB | 6 (24.0) | 3 (14.3) |
a
4-week administration/2-week rest.
b
2-week administration/1-week rest.